Literature DB >> 24467978

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.

Damien Gruson1, Thibault Lepoutre2, Sylvie A Ahn3, Michel F Rousseau3.   

Abstract

Entities:  

Keywords:  BNP; Biomarker; Heart failure; NT-proBNP; ST2; proBNP(1–108)

Mesh：

Substances：

Year:  2014        PMID： 24467978     DOI： 10.1016/j.ijcard.2013.12.101

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  13 in total

1.  Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.

Authors:  Charlotte Andersson; Sarah R Preis; Alexa Beiser; Charles DeCarli; Kai C Wollert; Thomas J Wang; James L Januzzi; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2015-07-28       Impact factor: 7.914

2.  Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Thomas Sommer; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

3.  Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis.

Authors:  Patrizio Lancellotti; Raluca Dulgheru; Julien Magne; Christine Henri; Laurence Servais; Nassim Bouznad; Arnaud Ancion; Christophe Martinez; Laurent Davin; Caroline Le Goff; Alain Nchimi; Luc Piérard; Cécile Oury
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

4.  Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.

Authors:  Mira T Keddis; Ziad El-Zoghby; Bruce Kaplan; Jeffrey W Meeusen; Leslie J Donato; Fernando G Cosio; D Eric Steidley
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

5.  Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease.

Authors:  Mohammed Laqqan; Christiane Schwaighofer; Stefan Graeber; Tanja Raedle-Hurst
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

6.  Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation.

Authors:  Helder Pereira; Tom A Jackson; Simon Claridge; Jonathan M Behar; Cheng Yao; Benjamin Sieniewicz; Justin Gould; Bradley Porter; Baldeep Sidhu; Jaswinder Gill; Steven Niederer; Christopher A Rinaldi
Journal:  Cardiol Res Pract       Date:  2019-02-21       Impact factor: 1.866

Review 7.  Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure.

Authors:  Humberto Villacorta; Alan S Maisel
Journal:  Arq Bras Cardiol       Date:  2016-01-15       Impact factor: 2.000

8.  ST2 and Galectin-3: Ready for Prime Time?

Authors:  Wouter C Meijers; A Rogier van der Velde; Rudolf A de Boer
Journal:  EJIFCC       Date:  2016-08-01

9.  Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.

Authors:  Pierre Frères; Nassim Bouznad; Laurence Servais; Claire Josse; Stéphane Wenric; Aurélie Poncin; Jérôme Thiry; Marie Moonen; Cécile Oury; Patrizio Lancellotti; Vincent Bours; Guy Jerusalem
Journal:  BMC Cancer       Date:  2018-01-29       Impact factor: 4.430

10.  Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome.

Authors:  Celestino Sardu; Raffaele Marfella; Matteo Santamaria; Stefano Papini; Quintino Parisi; Cosimo Sacra; Daniele Colaprete; Giuseppe Paolisso; Maria R Rizzo; Michelangela Barbieri
Journal:  Front Physiol       Date:  2018-06-26       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.